METHODS: A total of 26 patients were retrospectively enrolled, and the CLDN5 expression and permeability barrier dysfunction in vitro were assessed. Then miRNA-224-5p expression was also assessed in sensitive skin.
RESULTS: Immunofluorescence and electron microscopy revealed reduced CLDN5 expression, increased miR-224-5p expression, and disrupted intercellular junctions in sensitive skin. CLDN5 knockdown was associated with lower transepithelial electrical resistance (TEER) and Lucifer yellow penetration in keratinocytes and organotypic skin models. The RNA-seq and qRT-PCR results indicated elevated miR-224-5p expression in sensitive skin; MiR-224-5p directly interacted with the 3`UTR of CLDN5, resulting in CLDN5 deficiency in the luciferase reporter assay. Finally, miR-224-5p reduced TEER in keratinocyte cultures.
CONCLUSIONS: These results suggest that the miR-224-5p-induced reduction in CLDN5 expression leads to impaired permeability barrier function, and that miR-224-5p could be a potential therapeutic target for sensitive skin.
方法:回顾性纳入26例患者,并评估了CLDN5的表达和体外通透性屏障功能障碍。然后还在敏感皮肤中评估miRNA-224-5p表达。
结果:免疫荧光和电子显微镜显示CLDN5表达减少,miR-224-5p表达增加,敏感皮肤的细胞间连接被破坏。CLDN5敲低与较低的跨上皮电阻(TEER)和在角质形成细胞和器官型皮肤模型中的路西法黄渗透有关。RNA-seq和qRT-PCR结果表明,敏感皮肤中miR-224-5p表达升高;MiR-224-5p直接与CLDN5的3'UTR相互作用,导致荧光素酶报告基因测定中的CLDN5缺陷。最后,miR-224-5p降低角质形成细胞培养物中的TEER。
结论:这些结果表明,miR-224-5p诱导的CLDN5表达减少导致通透性屏障功能受损,miR-224-5p可能是敏感皮肤的潜在治疗靶点。